Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis
Asian Journal of Current Research in Clinical Cancer · 2025 · 5 (1) · 232-242
DOI: 10.51847/ea665c6fiw ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Current Research in Clinical Cancer, 2025. Verfasst von Wei Chen und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, W., & Zhang, L. (2025). Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis. Asian Journal of Current Research in Clinical Cancer, 5(1), 232-242. https://doi.org/10.51847/ea665c6fiw
Vancouver
Chen W, Zhang L. Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis. Asian Journal of Current Research in Clinical Cancer. 2025;5(1):232-242. doi:10.51847/ea665c6fiw
BibTeX
@article{Chen2025,
author = {Chen, Wei and Zhang, Li},
title = {Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis},
journal = {Asian Journal of Current Research in Clinical Cancer},
year = {2025},
volume = {5},
number = {1},
pages = {232--242},
doi = {10.51847/ea665c6fiw}
}
EUVIMED